MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS

Multiple-variable dose methods for treating TNFa-related disorders, including Crohn's disease and psoriasis, comprising administering TNFa inhibitors, including TNFa antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading ph...

Full description

Saved in:
Bibliographic Details
Main Authors Peng, Joanna Z, Paulson, Susan K, Chartash, Elliot Keith, Hoffman, Rebecca S, Granneman, George Richard, Yan, Philip, Taylor, Lori K
Format Patent
LanguageEnglish
Published 11.11.2021
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Multiple-variable dose methods for treating TNFa-related disorders, including Crohn's disease and psoriasis, comprising administering TNFa inhibitors, including TNFa antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the TNF-inhibitor is administered in a higher dosage during the induction phase.
AbstractList Multiple-variable dose methods for treating TNFa-related disorders, including Crohn's disease and psoriasis, comprising administering TNFa inhibitors, including TNFa antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the TNF-inhibitor is administered in a higher dosage during the induction phase.
Author Taylor, Lori K
Paulson, Susan K
Hoffman, Rebecca S
Peng, Joanna Z
Chartash, Elliot Keith
Granneman, George Richard
Yan, Philip
Author_xml – fullname: Peng, Joanna Z
– fullname: Paulson, Susan K
– fullname: Chartash, Elliot Keith
– fullname: Hoffman, Rebecca S
– fullname: Granneman, George Richard
– fullname: Yan, Philip
– fullname: Taylor, Lori K
BookMark eNqNyrsKwjAUANAMOvj6hwvOAdsqdY3mpgbSRm5S1xIk4lDSQP1_XPwAp7OcNVukKcUVU21vvL4b5A9BWlwMgrQOgbDRLXagLIEnFF53DfhOhTG_Ayc0wqMEqZ0lieS2bPkK4xx3Pzdsr9BfbzzmaYhzDs-Y4mfoXXkoi-pYn-uTKKr_1hfeoy_O
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2021347875A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2021347875A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:54:23 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2021347875A13
Notes Application Number: US202017125275
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211111&DB=EPODOC&CC=US&NR=2021347875A1
ParticipantIDs epo_espacenet_US2021347875A1
PublicationCentury 2000
PublicationDate 20211111
PublicationDateYYYYMMDD 2021-11-11
PublicationDate_xml – month: 11
  year: 2021
  text: 20211111
  day: 11
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies ABBVIE BIOTECHNOLOGY LTD
RelatedCompanies_xml – name: ABBVIE BIOTECHNOLOGY LTD
Score 3.370348
Snippet Multiple-variable dose methods for treating TNFa-related disorders, including Crohn's disease and psoriasis, comprising administering TNFa inhibitors,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211111&DB=EPODOC&locale=&CC=US&NR=2021347875A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PS8MwFH6MKepNp-J0SkDprbiuzdYdinRtulXWbvTH2G00bQaCdMNV_PdNQqc77ZbkQUgC7yVfku97AC99ins4KzJVy6i4raKGSlnGVNYdFmuz0IcmFmzkIOxPUuN9iZcN-NxzYaRO6I8UR-QelXN_r2S83v5fYrnyb-XulX7wps2bl1iuUqPjnggAmuKOLDKfuTNHcRwrjZUwkjZdCNFgm2OlE3GQFkr7ZDESvJTt4abiXcLpnPdXVlfQYGULzp197rUWnAX1kzcv1t63uwYvSKeJP58SdWFHvj2aEuTOYoIiMvYDEiIO6FASETvxwzFKQk_yaFWRFIOHJ-T6MQd8JIpv4NkjiTNR-YBWf_NfpfHh6PVbaJabkt0B0opiPegKPRxMjZytzQHV82Evz7WBbjKctaFzrKf74-YHuBBVQbzTtA40q69v9sh34Io-yYX7Bb88hLQ
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da8IwED_Ejbm3zW3sw22Bjb6VWWtsfZBR21S7tVX6Ib5J00YYjCqzY__-kqCbT76FHByXwN3xu-R3B_Dco7iDsyJTtYyKahXtqpRlTGXtfrE0C71vYsFGDsLeOO2-zfG8Bp87LozsE_ojmyNyj8q5v1cyXq__i1iO_Fu5eaEffGv16iYDR9mi444IAJriDAdkOnEmtmLbgzRWwkjKdNGIBlscKx0ZHBRKsDQbCl7Kej-puGdwPOX6yuocaqxsQsPezV5rwkmwffLmy633bS7ADVI_8aY-UWdW5FlDnyBnEhMUkZEXkBBxQIeSiFiJF45QErqSR6uKoRg8PCHHizngI1F8CU8uSeyxyg1a_J1_kcb71utXUC9XJbsGpBXF0miLfjiYdnO2NA2q5_1OnmuGbjKc3UDrkKbbw-JHaIyTwF_4Xvh-B6dCJEh4mtaCevX1ze55Nq7og7zEXxlFh54
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=MULTIPLE-VARIABLE+DOSE+REGIMEN+FOR+TREATING+TNFalpha-RELATED+DISORDERS&rft.inventor=Peng%2C+Joanna+Z&rft.inventor=Paulson%2C+Susan+K&rft.inventor=Chartash%2C+Elliot+Keith&rft.inventor=Hoffman%2C+Rebecca+S&rft.inventor=Granneman%2C+George+Richard&rft.inventor=Yan%2C+Philip&rft.inventor=Taylor%2C+Lori+K&rft.date=2021-11-11&rft.externalDBID=A1&rft.externalDocID=US2021347875A1